Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TTRX

+ Watchlist+ Portfolio

Turn Therapeutics Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$8.55
52-Week Range
$2.57 – $16.45
Market Cap
$271.79M
P/E (TTM)
—
EPS (TTM)
-0.43
Dividend Yield
0.00%
Advanced Metrics
Price/Book
47.80
PEG Ratio
—
Return on Equity
-412.27%
Return on Assets
-56.15%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
3.19
Debt/Equity
1.09
Total Debt
$6.23M
Free Cash Flow
$-2.62M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$267.66M

Market Snapshot

About

Turn Therapeutics is a clinical-stage biotechnology company focused on developing therapies for age-related diseases. The company is working on treatments that target cellular senescence and tissue regeneration to address conditions associated with aging. Turn Therapeutics is advancing a pipeline of novel therapeutics based on its proprietary regenerative medicine platform.